Suppression of piriform cortex activity in rat by corticotropin-releasing factor 1 and serotonin 2A/C receptors

Frontiers in Cellular Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Narla, Chakravarthi ^a   Dunn, Henry A ^a   Ferguson, Stephen S G ^a   Poulter, Michael O ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

5 hydroxytryptamine receptors; Adapting high frequency; Adapting low frequency; Corticotropin releasing factor 1 receptor; Corticotropin releasing factor; Dimethoxy 4 iodoamphetamine; Non adapting very high frequency; Piriform cortex

Indexed keywords

4 IODO 2, 5 DIMETHOXYAMPHETAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR 1; FORSKOLIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNEURON; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PATCH CLAMP TECHNIQUE; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; RAT; SIGNAL TRANSDUCTION; SPIKE; VOLTAGE SENSITIVE DYE IMAGING;

EID: 84930661603     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00200     Document Type: Article

References (49)

1. Aghajanian, G. K., and Davis, M. (1975). A method of direct chemical brain stimulation in behavioral studies using microiontophoresis. Pharmacol. Biochem. Behav. 3, 127-131. doi: 10.1016/0091-3057(75)90091-X
2. Aldenhoff, J. B., Gruol, D. L., Rivier, J., Vale, W., and Siggins, G. R. (1983). Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221, 875-877. doi: 10.1126/science.6603658
3. Anisman, H., Merali, Z., and Hayley, S. (2008). Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 85, 1-74. doi: 10.1016/j.pneurobio.2008.01.004
4. Anisman, H., Prakash, P., Merali, Z., and Poulter, M. O. (2007). Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav. Brain Res. 181, 180-190. doi: 10.1016/j.bbr.2007.04.002
5. Arborelius, L., Owens, M. J., Plotsky, P. M., and Nemeroff, C. B. (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160, 1-12. doi: 10.1677/joe.0.1600001
6. Ascoli, G. A., Alonso-Nanclares, L., Anderson, S. A., Barrionuevo, G., Benavides-Piccione, R., Burkhalter, A., et al. (2008). Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9, 557-568. doi: 10.1038/nrn2402
7. Birjandian, Z., Narla, C., and Poulter, M. O. (2013). Gain control of gamma frequency activation by a novel feed forward disinhibitory loop: implications for normal and epileptic neural activity. Front. Neural Circuits 7:183. doi: 10.3389/fncir.2013.00183
8. Blank, T., Nijholt, I., Grammatopoulos, D. K., Randeva, H. S., Hillhouse, E. W., and Spiess, J. (2003). Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23, 700-707.
9. Davis, M. (1992). The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15, 353-375. doi: 10.1146/annurev.ne.15.030192.002033
10. de Kloet, E. R., Joels, M., and Holsboer, F. (2005). Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475. doi: 10.1038/nrn1683
11. De Souza, E. B., Insel, T. R., Perrin, M. H., Rivier, J., Vale, W. W., and Kuhar, M. J. (1985). Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5, 3189-3203.
12. Dunn, H. A., Walther, C., Godin, C. M., Hall, R. A., and Ferguson, S. S. (2013). Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling. J. Biol. Chem. 288, 15023-15034. doi: 10.1074/jbc.M113.473660
13. Dunn, H. A., Walther, C., Yuan, G. Y., Caetano, F. A., Godin, C. M., and Ferguson, S. S. (2014). Role of SAP97 in the regulation of 5-HT2AR endocytosis and signaling. Mol. Pharmacol. 86, 275-283. doi: 10.1124/mol.114.093476
14. Eison, M. S. (1990). Serotonin: a common neurobiologic substrate in anxiety and depression. J. Clin. Psychopharmacol. 10, 26S-30S. doi: 10.1097/00004714-199006001-00006
15. Ekstrand, J. J., Domroese, M. E., Johnson, D. M., Feig, S. L., Knodel, S. M., Behan, M., et al. (2001). A new subdivision of anterior piriform cortex and associated deep nucleus with novel features of interest for olfaction and epilepsy. J. Comp. Neurol. 434, 289-307. doi: 10.1002/cne.1178
16. Elliott-Hunt, C. R., Kazlauskaite, J., Wilde, G. J., Grammatopoulos, D. K., and Hillhouse, E. W. (2002). Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 80, 416-425. doi: 10.1046/j.0022-3042.2001.00712.x
17. Ferguson, S. S., and Caron, M. G. (2004). Green fluorescent protein-tagged beta-arrestin translocation as a measure of G protein-coupled receptor activation. Methods Mol. Biol. 237, 121-126.
18. Fu, Y., and Neugebauer, V. (2008). Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J. Neurosci. 28, 3861-3876. doi: 10.1523/JNEUROSCI.0227-08.2008
19. Gavrilovici, C., Pollock, E., Everest, M., and Poulter, M. O. (2012). The loss of interneuron functional diversity in the piriform cortex after induction of experimental epilepsy. Neurobiol. Dis. 48, 317-328. doi: 10.1016/j.nbd.2012.07.002
20. Hayley, S., Poulter, M. O., Merali, Z., and Anisman, H. (2005). The pathogenesis of clinical depression: stressor-and cytokine-induced alterations of neuroplasticity. Neuroscience 135, 659-678. doi: 10.1016/j.neuroscience.2005.03.051
21. Hollrigel, G. S., Chen, K., Baram, T. Z., and Soltesz, I. (1998). The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 84, 71-79. doi: 10.1016/S0306-4522(97)00499-5
22. Kadohisa, M. (2013). Effects of odor on emotion, with implications. Front. Syst. Neurosci. 7:66. doi: 10.3389/fnsys.2013.00066
23. Kahn, R. S., van Praag, H. M., Wetzler, S., Asnis, G. M., and Barr, G. (1988). Serotonin and anxiety revisited. Biol. Psychiatry 23, 189-208. doi: 10.1016/0006-3223(88)90091-1
24. Kirby, L. G., Rice, K. C., and Valentino, R. J. (2000). Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22, 148-162. doi: 10.1016/S0893-133X(99)00093-7
25. Kratzer, S., Mattusch, C., Metzger, M. W., Dedic, N., Noll-Hussong, M., Kafitz, K. W., et al. (2013). Activation of CRH receptor type 1 expressed on glutamatergic neurons increases excitability of CA1 pyramidal neurons by the modulation of voltage-gated ion channels. Front. Cell. Neurosci. 7:91. doi: 10.3389/fncel.2013.00091
26. Kroner, S., Krimer, L. S., Lewis, D. A., and Barrionuevo, G. (2007). Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb. Cortex 17, 1020-1032. doi: 10.1093/cercor/bhl012
27. Krusemark, E. A., Novak, L. R., Gitelman, D. R., and Li, W. (2013). When the sense of smell meets emotion: anxiety-state-dependent olfactory processing and neural circuitry adaptation. J. Neurosci. 33, 15324-15332. doi: 10.1523/JNEUROSCI.1835-13.2013
28. Loscher, W., and Ebert, U. (1996). The role of the piriform cortex in kindling. Prog. Neurobiol. 50, 427-481. doi: 10.1016/S0301-0082(96)00036-6
29. Magalhaes, A. C., Holmes, K. D., Dale, L. B., Comps-Agrar, L., Lee, D., Yadav, P. N., et al. (2010). CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat. Neurosci. 13, 622-629. doi: 10.1038/nn.2529
30. Marek, G. J., and Aghajanian, G. K. (1994). Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. Eur. J. Pharmacol. 259, 137-141. doi: 10.1016/0014-2999(94)90502-9
31. Marek, G. J., and Aghajanian, G. K. (1996). LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J. Pharmacol. Exp. Ther. 278, 1373-1382.
32. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873-904. doi: 10.1152/physrev.00041.2006
33. McIntyre, D. C., Hutcheon, B., Schwabe, K., and Poulter, M. O. (2002). Divergent GABA(A) receptor-mediated synaptic transmission in genetically seizure-prone and seizure-resistant rats. J. Neurosci. 22, 9922-9931.
34. Merali, Z., Khan, S., Michaud, D. S., Shippy, S. A., and Anisman, H. (2004). Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release. Eur. J. Neurosci. 20, 229-239. doi: 10.1111/j.1460-9568.2004.03468.x
35. Mora, F., Segovia, G., Del, A. A., de, B. M., and Garrido, P. (2012). Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res. 1476, 71-85. doi: 10.1016/j.brainres.2011.12.049
36. Muller, M. B., Zimmermann, S., Sillaber, I., Hagemeyer, T. P., Deussing, J. M., Timpl, P., et al. (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6, 1100-1107. doi: 10.1038/nn1123
37. Naughton, M., Mulrooney, J. B., and Leonard, B. E. (2000). A review of the role of serotonin receptors in psychiatric disorders. Hum. Psychopharmacol. 15, 397-415. doi: 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L
38. Pazos, A., Cortes, R., and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231-249. doi: 10.1016/0006-8993(85)90857-1
39. Primus, R. J., Yevich, E., Baltazar, C., and Gallager, D. W. (1997). Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 17, 308-316. doi: 10.1016/S0893-133X(97)00071-7
40. Risbrough, V. B., and Stein, M. B. (2006). Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm. Behav. 50, 550-561. doi: 10.1016/j.yhbeh.2006.06.019
41. Sheldon, P. W., and Aghajanian, G. K. (1990). Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron. Brain Res. 506, 62-69. doi: 10.1016/0006-8993(90)91199-Q
42. Sheldon, P. W., and Aghajanian, G. K. (1991). Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Synapse 9, 208-218. doi: 10.1002/syn.890090307
43. Sheng, H., Zhang, Y., Sun, J., Gao, L., Ma, B., Lu, J., et al. (2008). Corticotropin-releasing hormone (CRH) depresses n-methyl-D-aspartate receptor-mediated current in cultured rat hippocampal neurons via CRH receptor type 1. Endocrinology 149, 1389-1398. doi: 10.1210/en.2007-1378
44. Tan, H., Zhong, P., and Yan, Z. (2004). Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J. Neurosci. 24, 5000-5008. doi: 10.1523/JNEUROSCI.0143-04.2004
45. Tao, F., Su, Q., and Johns, R. A. (2008). Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice. Mol. Ther. 16, 1776-1782. doi: 10.1038/mt.2008.192
46. Van, P. K., Viau, V., Bittencourt, J. C., Chan, R. K., Li, H. Y., Arias, C., et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428, 191-212. doi: 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
47. von, W. G., Avrabos, C., Stepan, J., Wurst, W., Deussing, J. M., Holsboer, F., et al. (2011). Voltage-sensitive dye imaging demonstrates an enhancing effect of corticotropin-releasing hormone on neuronal activity propagation through the hippocampal formation. J. Psychiatr. Res. 45, 256-261. doi: 10.1016/j.jpsychires.2010.06.007
48. Wietfeld, D., Heinrich, N., Furkert, J., Fechner, K., Beyermann, M., Bienert, M., et al. (2004). Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J. Biol. Chem. 279, 38386-38394. doi: 10.1074/jbc.M405335200
49. Zorrilla, E. P., Logrip, M. L., and Koob, G. F. (2014). Corticotropin releasing factor: a key role in the neurobiology of addiction. Front. Neuroendocrinol. 35:234-244. doi: 10.1016/j.yfrne.2014.01.001